Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 227

1.

Safety profile of the fluoroquinolones: analysis of adverse drug reactions in relation to prescription data using four regional pharmacovigilance databases in Italy.

Lapi F, Tuccori M, Motola D, Pugi A, Vietri M, Montanaro N, Vaccheri A, Leoni O, Cocci A, Leone R, Conforti A, Moretti U, Sessa E, Mazzaglia G, Mugelli A, Mazzei T, Vannacci A.

Drug Saf. 2010 Sep 1;33(9):789-99. doi: 10.2165/11536810-000000000-00000.

PMID:
20701411
2.

Adverse drug reactions related to the use of fluoroquinolone antimicrobials: an analysis of spontaneous reports and fluoroquinolone consumption data from three italian regions.

Leone R, Venegoni M, Motola D, Moretti U, Piazzetta V, Cocci A, Resi D, Mozzo F, Velo G, Burzilleri L, Montanaro N, Conforti A.

Drug Saf. 2003;26(2):109-20.

PMID:
12534327
3.

Global patterns of adverse drug reactions over a decade: analyses of spontaneous reports to VigiBase™.

Aagaard L, Strandell J, Melskens L, Petersen PS, Holme Hansen E.

Drug Saf. 2012 Dec 1;35(12):1171-82. doi: 10.2165/11631940-000000000-00000.

PMID:
23072620
4.

Drug-induced anaphylaxis : case/non-case study based on an italian pharmacovigilance database.

Leone R, Conforti A, Venegoni M, Motola D, Moretti U, Meneghelli I, Cocci A, Sangiorgi Cellini G, Scotto S, Montanaro N, Velo G.

Drug Saf. 2005;28(6):547-56.

PMID:
15924506
5.

Statin-associated psychiatric adverse events: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting.

Tuccori M, Lapi F, Testi A, Coli D, Moretti U, Vannacci A, Motola D, Salvo F, Rivolta AL, Blandizzi C, Mugelli A, Del Tacca M.

Drug Saf. 2008;31(12):1115-23. doi: 10.2165/0002018-200831120-00007.

PMID:
19026028
6.

Use and safety profile of antiepileptic drugs in Italy.

Iorio ML, Moretti U, Colcera S, Magro L, Meneghelli I, Motola D, Rivolta AL, Salvo F, Velo GP.

Eur J Clin Pharmacol. 2007 Apr;63(4):409-15. Epub 2007 Feb 16.

PMID:
17347806
7.

Ten years of pharmacovigilance in Italy: the experience of Emilia-Romagna region in the monitoring of drug's safety profile.

Motola D, Melis M, Lo Bianco S, Buccellato E, Biagi C, Vaccheri A.

Expert Opin Drug Saf. 2014 Jul;13(7):867-73. doi: 10.1517/14740338.2014.916687. Epub 2014 May 8.

PMID:
24809453
8.

Fluvastatin and hepatic reactions: a signal from spontaneous reporting in Italy.

Conforti A, Magro L, Moretti U, Scotto S, Motola D, Salvo F, Ros B, Leone R.

Drug Saf. 2006;29(12):1163-72.

PMID:
17147462
9.

Effect of pharmacist involvement on patient reporting of adverse drug reactions: first Italian study.

Leone R, Moretti U, D'Incau P, Conforti A, Magro L, Lora R, Velo G.

Drug Saf. 2013 Apr;36(4):267-76. doi: 10.1007/s40264-013-0028-8.

PMID:
23475583
10.

Adverse drug reactions for CAM and conventional drugs detected in a network of physicians certified to prescribe CAM drugs.

Tabali M, Ostermann T, Jeschke E, Witt CM, Matthes H.

J Manag Care Pharm. 2012 Jul-Aug;18(6):427-38.

11.

Mapping the safety profile of biologicals: a disproportionality analysis using the WHO adverse drug reaction database, VigiBase.

Giezen TJ, Mantel-Teeuwisse AK, Meyboom RH, Straus SM, Leufkens HG, Egberts TC.

Drug Saf. 2010 Oct 1;33(10):865-78. doi: 10.2165/11538330-000000000-00000.

PMID:
20812771
12.

First French experience of ADR reporting by patients after a mass immunization campaign with Influenza A (H1N1) pandemic vaccines: a comparison of reports submitted by patients and healthcare professionals.

Durrieu G, Palmaro A, Pourcel L, Caillet C, Faucher A, Jacquet A, Ouaret S, Perault-Pochat MC, Kreft-Jais C, Castot A, Lapeyre-Mestre M, Montastruc JL; French Network of Pharmacovigilance Centres..

Drug Saf. 2012 Oct 1;35(10):845-54. doi: 10.2165/11631800-000000000-00000.

PMID:
22967189
13.

Drug-related deaths: an analysis of the Italian spontaneous reporting database.

Leone R, Sottosanti L, Luisa Iorio M, Santuccio C, Conforti A, Sabatini V, Moretti U, Venegoni M.

Drug Saf. 2008;31(8):703-13.

PMID:
18636789
14.

Safety profile of antiviral medications: a pharmacovigilance study using the Italian spontaneous-reporting database.

Pugi A, Bonaiuti R, Maggini V, Moschini M, Tuccori M, Leone R, Rossi M, Motola D, Piccinni C, Ferrazin F, Sottosanti L, Mugelli A, Vannacci A, Lapi F.

Am J Health Syst Pharm. 2013 Jun 15;70(12):1039-46. doi: 10.2146/ajhp120665.

PMID:
23719881
15.

Cutaneous reactions to drugs. An analysis of spontaneous reports in four Italian regions.

Naldi L, Conforti A, Venegoni M, Troncon MG, Caputi A, Ghiotto E, Cocci A, Moretti U, Velo G, Leone R.

Br J Clin Pharmacol. 1999 Dec;48(6):839-46.

16.
17.

Comparison between paediatric and adult suspected adverse drug reactions reported to the European medicines agency: implications for pharmacovigilance.

Blake KV, Zaccaria C, Domergue F, La Mache E, Saint-Raymond A, Hidalgo-Simon A.

Paediatr Drugs. 2014 Aug;16(4):309-19. doi: 10.1007/s40272-014-0076-2.

PMID:
24898717
18.

Musculoskeletal adverse drug reactions: a review of literature and data from ADR spontaneous reporting databases.

Conforti A, Chiamulera C, Moretti U, Colcera S, Fumagalli G, Leone R.

Curr Drug Saf. 2007 Jan;2(1):47-63. Review.

PMID:
18690950
19.

Adverse reactions to fluoroquinolones in the Nigerian population: an audit of reports submitted to the National Pharmacovigilance Centre from 2004 to 2016.

Oreagba IA, Oshikoya KA, Ogar C, Adefurin AO, Ibrahim A, Awodele O, Oni Y.

Pharmacol Res Perspect. 2017 Feb 14;5(2):e00297. doi: 10.1002/prp2.297. eCollection 2017 Apr.

20.

Identifying adverse drug reactions associated with drug-drug interactions: data mining of a spontaneous reporting database in Italy.

Leone R, Magro L, Moretti U, Cutroneo P, Moschini M, Motola D, Tuccori M, Conforti A.

Drug Saf. 2010 Aug 1;33(8):667-75. doi: 10.2165/11534400-000000000-00000.

PMID:
20635825

Supplemental Content

Support Center